| Probiotic Supplementation in Patients with Alzheimer's Dementia - An Explorative Intervention Study |
34 |
| Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies |
23 |
| A Speech Recognition-based Solution for the Automatic Detection of Mild Cognitive Impairment from Spontaneous Speech |
22 |
| Lipid Biomarkers in Alzheimer's Disease |
20 |
| Long Non-coding RNA MALAT1 Inhibits Neuron Apoptosis and Neuroinflammation While Stimulates Neurite Outgrowth and Its Correlation With MiR-125b Mediates PTGS CDK5 and FOXQ1 in Alzheimer's Disease |
17 |
| Distinctive Effects of Aerobic and Resistance Exercise Modes on Neuro-cognitive and Biochemical Changes in Individuals with Mild Cognitive Impairment |
14 |
| Advances on Automatic Speech Analysis for Early Detection of Alzheimer Disease: A Non-linear Multi-task Approach |
14 |
| The Role of Lipids and Membranes in the Pathogenesis of Alzheimer's Disease: A Comprehensive View |
13 |
| Sex and Gender Differences in the Brain Cholinergic System and in the Response to Therapy of Alzheimer Disease with Cholinesterase Inhibitors |
12 |
| Crosstalk between Gut Microbiota and Central Nervous System: A Focus on Alzheimer's Disease |
11 |
| Does Intraneuronal Accumulation of Carboxyl-terminal Fragments of the Amyloid Precursor Protein Trigger Early Neurotoxicity in Alzheimer's Disease? |
11 |
| Systemic and CNS Inflammation Crosstalk: Implications for Alzheimer's Disease |
11 |
| The Involvement of Post-Translational Modifications in Alzheimer's Disease |
11 |
| Mitigating Alzheimer's Disease with Natural Polyphenols: A Review |
10 |
| Resveratrol Rescues Tau-Induced Cognitive Deficits and Neuropathology in a Mouse Model of Tauopathy |
10 |
| Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers |
9 |
| Biomarkers for Alzheimer's Disease |
9 |
| Pharmacogenetics of Angiotensin-Converting Enzyme Inhibitors in Patients with Alzheimer's Disease Dementia |
9 |
| Modulation of Inflammation as a Way of Delaying Alzheimer's Disease Progression: The Diet's Role |
9 |
| The Temporal Relationship between Pain Intensity and Pain Interference and Incident Dementia |
9 |
| The Implications of Autophagy in Alzheimer's Disease |
9 |
| Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting beta/gamma-Secretases Activity and Enhancing alpha-Secretases |
8 |
| Effects of Molecular Hydrogen Assessed by an Animal Model and a Randomized Clinical Study on Mild Cognitive Impairment |
8 |
| Targeting PPARalpha in Alzheimer's Disease |
8 |
| Neuroinflammation in Alzheimer's Disease: Microglia, Molecular Participants and Therapeutic Choices |
8 |
| Global view on Alzheimer's Disease and Diabetes Mellitus: Threats, Risks and Treatment Alzheimer's Disease and Diabetes Mellitus |
8 |
| Upregulation of Suppressor of Cytokine Signaling 3 in Microglia by Cinnamic Acid |
8 |
| Therapeutic Strategies Targeting Amyloid-beta in Alzheimer's Disease |
7 |
| Heart Rate Variability Indexes in Dementia: A Systematic Review with a Quantitative Analysis |
7 |
| Phenolic Acids Exert Anticholinesterase and Cognition-Improving Effects |
7 |
| Dietary Fat Intake and Risk of Alzheimer's Disease and Dementia: A Meta-Analysis of Cohort Studies |
7 |
| Oxidative Stress and Decreased Mitochondrial Superoxide Dismutase 2 and Peroxiredoxins 1 and 4 Based Mechanism of Concurrent Activation of AMPK and mTOR in Alzheimer's Disease |
7 |
| Insights into the Drug Repositioning Applied to the Alzheimer's Disease Treatment and Future Perspectives |
7 |
| Astrocytic alpha 7 Nicotinic Receptor Activation Inhibits Amyloid-beta Aggregation by Upregulating Endogenous alpha beta-crystallin through the PI3K/Akt Signaling Pathway |
7 |
| A Pilot Study of Exenatide Actions in Alzheimer's Disease |
7 |
| Impact of a Clinical Decision Support Tool on Dementia Diagnostics in Memory Clinics: The PredictND Validation Study |
7 |
| Inhibition of microRNA-155 Alleviates Cognitive Impairment in Alzheimer's Disease and Involvement of Neuroinflammation |
6 |
| Auditory Event-related Potentials in Mild Cognitive Impairment and Alzheimer's Disease |
6 |
| Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia |
6 |
| Visual Event-Related Potentials in Mild Cognitive Impairment and Alzheimer's Disease: A Literature Review |
6 |
| Is it All Said for NSAI Ds in Alzheimer's Disease? Role of Mitochondrial Calcium Uptake |
6 |
| Use of Speech Analyses within a Mobile Application for the Assessment of Cognitive Impairment in Elderly People |
6 |
| In Silico Evaluation of Acetylation Mimics in the 27 Lysine Residues of Human Tau Protein |
6 |
| The CSF p-tau181/A beta 42 Ratio Offers a Good Accuracy In Vivo in the Differential Diagnosis of Alzheimer's Dementia |
5 |
| Microdose Lithium NP03 Diminishes Pre-Plaque Oxidative Damage and Neuroinflammation in a Rat Model of Alzheimer's-Like Amyloidosis |
5 |
| Voice Markers of Lexical Access in Mild Cognitive Impairment and Alzheimer's Disease |
5 |
| Ginkgo biloba Extract EGb761 Attenuates Hyperhomocysteinemia-induced AD Like Tau Hyperphosphorylation and Cognitive Impairment in Rats |
5 |
| Technological Solutions for Older People with Alzheimer's Disease: Review |
5 |
| Catechol-O-methyltransferase, Cognition and Alzheimer's Disease |
5 |
| The Correlations between Postmortem Brain Pathologies and Cognitive Dysfunction in Aging and Alzheimer's Disease |
5 |
